Transplant & Hematology

Haploidentical Transplant in China

For patients without a fully matched donor, haploidentical stem cell transplantation — using a half-matched parent, sibling, or child as donor — is an established option with documented clinical experience at specialised Chinese haematology centres. The Beijing Protocol, developed at Peking University Institute of Hematology, has been validated in published international studies and is used as a reference approach at multiple transplant centres in China.

Key Topics Covered

What haploidentical transplant means and who it may be relevant for
The Beijing Protocol — what it is and what the evidence shows
Parent donors and other haploidentical family donors
Haplo-HSCT for leukemia, aplastic anaemia, and blood disorders
Eligibility for adult and paediatric patients
Outcomes data from peer-reviewed international publications
CAR-T combined with haploidentical transplant
How to request a structured case review

Articles & Guides

Additional articles on haploidentical transplant for specific conditions are being prepared. Check back or contact us to request specific topics.

Request a Structured Transplant Case Review

If donor shortage, transplant eligibility, or relapse after transplant is a concern for your family, a structured case review can help clarify whether haploidentical transplant in China may be relevant.